Global and China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Insights, Forecast to 2027

Global and China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
1.2 Market by Type
1.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Type
1.2.2 Serotype 6B
1.2.3 7F Serotype
1.2.4 Serotype 9V
1.2.5 14 Serotype
1.2.6 Serotype 18C
1.2.7 Serotype 19A
1.2.8 19F Serotype
1.2.9 23F Serotype
1.2.10 24F Serotype
1.2.11 Other
1.3 Market by Application
1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Application
1.3.2 Infants from 6 Weeks to 15 Months Old
1.3.3 Children Aged 15 Months to 5 Years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, Estimates and Forecasts
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2027
2.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2027
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13), Market Size by Region: 2016 VS 2021 VS 2027
2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historical Market Size by Region (2016-2021)
2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2022-2027)
2.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2022-2027)
3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Competitor Landscape by Players
3.1 Global Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers by Sales
3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Manufacturer (2016-2021)
3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers by Revenue
3.2.1 Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Covered: Ranking by Revenue
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Manufacturers (2016-2021)
3.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2020
3.2.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Manufacturers
3.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base Distribution, Product Types
3.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
3.4.3 Date of International Manufacturers Enter into 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type (2016-2021)
4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021)
4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2016-2021)
4.1.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Type (2022-2027)
4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2022-2027)
4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2022-2027)
4.2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application (2016-2021)
5.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021)
5.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2016-2021)
5.1.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2016-2021)
5.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Application (2022-2027)
5.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2022-2027)
5.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2022-2027)
5.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
6.1.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales YoY Growth 2016-2027
6.1.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue YoY Growth 2016-2027
6.1.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share in Global Market 2016-2027
6.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Players (International and Local Players)
6.2.1 China Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players by Sales (2016-2021)
6.2.2 China Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players by Revenue (2016-2021)
6.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Review by Type (2016-2021)
6.3.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
6.3.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
6.3.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2016-2021)
6.4 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2022-2027)
6.4.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2022-2027)
6.4.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Type (2022-2027)
6.5 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Review by Application (2016-2021)
6.5.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
6.5.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2016-2021)
6.5.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2016-2021)
6.6 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2022-2027)
6.6.2 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2022-2027)
6.6.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Application (2022-2027)
7 North America
7.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
7.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
7.2.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
7.2.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
8.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Region
8.2.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021)
8.2.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
9.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
9.2.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
9.2.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
10.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
10.2.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
10.2.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
11.2.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
11.2.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.1.5 Pfizer Recent Development
12.2 Minhai Bio
12.2.1 Minhai Bio Corporation Information
12.2.2 Minhai Bio Description and Business Overview
12.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.2.5 Minhai Bio Recent Development
12.3 Kexing Bio
12.3.1 Kexing Bio Corporation Information
12.3.2 Kexing Bio Description and Business Overview
12.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.3.5 Kexing Bio Recent Development
12.4 Cansino Bio
12.4.1 Cansino Bio Corporation Information
12.4.2 Cansino Bio Description and Business Overview
12.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.4.5 Cansino Bio Recent Development
12.5 Lanzhou Biological Preparations Institute
12.5.1 Lanzhou Biological Preparations Institute Corporation Information
12.5.2 Lanzhou Biological Preparations Institute Description and Business Overview
12.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.5.5 Lanzhou Biological Preparations Institute Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Trends
13.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
13.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
13.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Serotype 6B
Table 3. Major Manufacturers of 7F Serotype
Table 4. Major Manufacturers of Serotype 9V
Table 5. Major Manufacturers of 14 Serotype
Table 6. Major Manufacturers of Serotype 18C
Table 7. Major Manufacturers of Serotype 19A
Table 8. Major Manufacturers of 19F Serotype
Table 9. Major Manufacturers of 23F Serotype
Table 10. Major Manufacturers of 24F Serotype
Table 11. Major Manufacturers of Other
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Regions (2016-2021) & (K Units)
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Regions (2016-2021)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Regions (2016-2021) & (US$ Million)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2022-2027) & (K Units)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Region (2022-2027)
Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Region (2022-2027)
Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Manufacturers (2016-2021) (K Units)
Table 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Manufacturers (2016-2021)
Table 23. Ranking of Global Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers by Revenue (US$ Million) in 2020
Table 24. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers (2016-2021)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) as of 2020)
Table 28. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (2016-2021) (US$/Unit)
Table 29. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 31. Date of International Manufacturers Enter into 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) (K Units)
Table 34. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Type (2016-2021)
Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2016-2021) (US$ Million)
Table 36. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Type (2016-2021)
Table 37. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 38. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2022-2027) & (K Units)
Table 39. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2022-2027)
Table 40. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast V (2022-2027) & (US$ Million)
Table 41. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Type (2022-2027)
Table 42. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 43. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) (K Units)
Table 44. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Application (2016-2021)
Table 45. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2016-2021) (US$ Million)
Table 46. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Application (2016-2021)
Table 47. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 48. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2022-2027) & (K Units)
Table 49. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Application (2022-2027)
Table 50. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 51. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Application (2022-2027)
Table 52. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 53. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) of Key Companies (2016-2021)
Table 54. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Company (2016-2021)
Table 55. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) by Company (2016-2021)
Table 56. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Company (2016-2021)
Table 57. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) by Type (2016-2021)
Table 58. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Type (2016-2021)
Table 59. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 60. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit) by Type (2016-2021)
Table 61. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) by Type (2022-2027)
Table 62. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Type (2022-2027)
Table 63. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 64. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Type (2022-2027)
Table 65. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit) by Type (2022-2027)
Table 66. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) by Application (2016-2021)
Table 67. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Application (2016-2021)
Table 68. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 69. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit) by Application (2016-2021)
Table 70. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) by Application (2022-2027)
Table 71. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Application (2022-2027)
Table 72. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 73. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Application (2022-2027)
Table 74. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit) by Application (2022-2027)
Table 75. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 76. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 77. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & (US$ Million)
Table 78. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 79. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Table 81. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Table 83. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 84. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 85. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 87. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 88. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 89. Latin Americaa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & (US$ Million)
Table 90. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 91. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 92. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 93. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & (US$ Million)
Table 94. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 98. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 99. Pfizer Recent Development
Table 100. Minhai Bio Corporation Information
Table 101. Minhai Bio Description and Business Overview
Table 102. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 103. Minhai Bio Product
Table 104. Minhai Bio Recent Development
Table 105. Kexing Bio Corporation Information
Table 106. Kexing Bio Description and Business Overview
Table 107. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Kexing Bio Product
Table 109. Kexing Bio Recent Development
Table 110. Cansino Bio Corporation Information
Table 111. Cansino Bio Description and Business Overview
Table 112. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Cansino Bio Product
Table 114. Cansino Bio Recent Development
Table 115. Lanzhou Biological Preparations Institute Corporation Information
Table 116. Lanzhou Biological Preparations Institute Description and Business Overview
Table 117. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Lanzhou Biological Preparations Institute Product
Table 119. Lanzhou Biological Preparations Institute Recent Development
Table 120. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Trends
Table 121. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
Table 122. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
Table 123. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints
Table 124. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers List
Table 125. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Picture
Figure 2. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020 & 2027
Figure 3. Serotype 6B Product Picture
Figure 4. 7F Serotype Product Picture
Figure 5. Serotype 9V Product Picture
Figure 6. 14 Serotype Product Picture
Figure 7. Serotype 18C Product Picture
Figure 8. Serotype 19A Product Picture
Figure 9. 19F Serotype Product Picture
Figure 10. 23F Serotype Product Picture
Figure 11. 24F Serotype Product Picture
Figure 12. Other Product Picture
Figure 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020 & 2027
Figure 14. Infants from 6 Weeks to 15 Months Old
Figure 15. Children Aged 15 Months to 5 Years
Figure 16. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Report Years Considered
Figure 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size 2016-2027 (US$ Million)
Figure 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2027 (K Units)
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2020
Figure 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region in 2020
Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2020
Figure 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global 13-Val

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs